Back
Day Range
$35.15
$36.30
52-Week Range
$21.97
$48.25
Volume
420,628
50D / 200D Avg
$39.51
/
$39.76
Prev Close
$35.31
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 175.1 | 0.4 |
| P/B | 3.8 | 2.9 |
| ROE % | 2.7 | 3.7 |
| Net Margin % | 2.2 | 3.9 |
| Rev Growth 5Y % | 10.2 | 10.0 |
| D/E | 0.7 | 0.2 |
Analyst Price Target
Hold
$52.00
+45.6%
Low: $50.00
High: $55.00
Forward P/E
100.0
Forward EPS
$0.36
EPS Growth (est.)
+0.0%
Est. Revenue
490 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$1.72
$1.69 – $1.73
|
790 M | 1 |
| FY2029 |
$1.33
$1.31 – $1.34
|
700 M | 1 |
| FY2028 |
$0.87
$0.76 – $0.97
|
620 M | 2 |
Key Takeaways
Revenue grew 10.24% annually over 5 years — strong growth
ROE of 2.70% is below average
Negative free cash flow of -911,000.0
P/E of 175.10 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.35%
Capital efficient — spends only 8.85% of revenue on capex
Growth
Revenue Growth (5Y)
10.24%
Revenue (1Y)13.59%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
2.70%
ROIC2.71%
Net Margin2.21%
Op. Margin6.06%
Safety
Debt / Equity
0.65
Current Ratio2.99
Interest Coverage1.01
Valuation
P/E Ratio
175.10
P/B Ratio3.82
EV/EBITDA72.45
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13.59% | Revenue Growth (3Y) | 11.65% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 10.24% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 441.33M | Net Income (TTM) | 9.77M |
| ROE | 2.70% | ROA | 1.10% |
| Gross Margin | 61.28% | Operating Margin | 6.06% |
| Net Margin | 2.21% | Free Cash Flow (TTM) | -911,000.0 |
| ROIC | 2.71% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.65 | Current Ratio | 2.99 |
| Interest Coverage | 1.01 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 175.10 | P/B Ratio | 3.82 |
| P/S Ratio | 3.88 | PEG Ratio | -1.25 |
| EV/EBITDA | 72.45 | Dividend Yield | 0.00% |
| Market Cap | 1.71B | Enterprise Value | 1.94B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 441.33M | 388.54M | 354.00M | 313.79M | 298.84M |
| Net Income | 9.77M | -13.36M | -30.69M | -19.19M | -14.83M |
| EPS (Diluted) | 0.21 | -0.32 | -0.75 | -0.48 | -0.38 |
| Gross Profit | 270.45M | 248.78M | 229.18M | 202.52M | 197.51M |
| Operating Income | 26.75M | 38.87M | 5.74M | 6.20M | 8.12M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 884.80M | 789.10M | 792.40M | 762.80M | 793.05M |
| Total Liabilities | 436.56M | 512.90M | 510.62M | 478.47M | 492.32M |
| Shareholders' Equity | 448.23M | 276.20M | 281.78M | 284.33M | 300.73M |
| Total Debt | 292.04M | 362.26M | 358.34M | 356.83M | 362.04M |
| Cash & Equivalents | 64.91M | 53.46M | 58.94M | 39.35M | 55.01M |
| Current Assets | 303.55M | 290.08M | 280.67M | 247.33M | 247.70M |
| Current Liabilities | 101.56M | 66.82M | 57.86M | 49.68M | 44.95M |